MorphoSys AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other
companies in this sector in UNITED STATES :
sales of $78.00 million
Adaptive Biotechnologies Corp
of which 100%
was Biotechnology & Medical Research), and
Luna Innovations Incorporated
of which 63%
was Products and licensing).
During the year ended December of 2019, sales at
MorphoSys AG were $80.20 million.
decrease of 11.0%
versus 2018, when the company's sales were $90.07 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, MorphoSys AG had sales
of $84.48 million.
Contributing to the drop in overall sales was the 39.3% decline
in Proprietary Development, from $63.17 million to $38.32 million.
However, these declines were partially offset by the increase in sales of
Partnered Discovery (up 55.7% to $41.88 million)